Time Course of the Effects of Buxin Yishen Decoction in Promoting Heart Function and Inhibiting the Progression of Renal Fibrosis in Myocardial Infarction Caused Type 2 Cardiorenal Syndrome Rats

Time Course of the Effects of Buxin Yishen Decoction in Promoting Heart Function and Inhibiting the Progression of Renal Fibrosis in Myocardial Infarction Caused Type 2 Cardiorenal Syndrome Rats

This study aimed to investigate the therapeutic effect of traditional Chinese medicine-Buxin Yishen decoction (BXYS) on type 2 cardiorenal syndrome (CRS) caused by myocardial infarction and explore the possible mechanism BXYS works. A chronic heart failure (CHF) rat model induced by left anterior de...

Full description

Bibliographic Details
Main Authors:	Qi Qiu, Jinglin Cao, Yong Wang, Yunnan Zhang, Yun Wei, Xiaoyan Hao, Yu Mu, Yang Lin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-10-01
Series:	Frontiers in Pharmacology
Subjects:	Buxin Yinshen decoction cardiorenal syndrome renal fibrosis heart function connective tissue growth factor
Online Access:	https://www.frontiersin.org/article/10.3389/fphar.2019.01267/full

Similar Items

Prevention of acute radiation-associated toxicity by traditional Chinese medicine Tianwang buxin mini-pills in patients with head and neck cancer
by: Kao-Shin Lin, et al.
Published: (2014-01-01)

Fibrosis, the Bad Actor in Cardiorenal Syndromes: Mechanisms Involved
by: Beatriz Delgado-Valero, et al.
Published: (2021-07-01)

Role of macrophages in cardiorenal syndrome development in patients with myocardial infarction
by: M. A. Kercheva, et al.
Published: (2021-05-01)

Chronic Secondary Cardiorenal Syndrome: The Sixth Innovative Subtype
by: Yipeng Zhang, et al.
Published: (2021-03-01)

Síndrome cardiorenal
by: V. Marcelo Llancaqueo, Dr.
Published: (2010-07-01)

Cardiorenal Syndrome: Diagnosis and Treatment
by: O.O. Melnyk
Published: (2017-02-01)

Cardiorenal and hepatorenal syndrome
by: Anand Bhutada, et al.
Published: (2018-01-01)

Hypertension in pregnant women - a novel cardiorenal continuum
by: Il'shat Ravilevich Gaysin, et al.
Published: (2012-01-01)

Factors for the development and progression of cardiorenal complications in women
by: E N Chicherina, et al.
Published: (2013-06-01)

Influence of Yishen Guben Qutong decoction combined with menatetrenone soft capsule on bone metabolism, bone conversion index and clinical efficacy in osteoporosis patients
by: Hong-Tao Qiu, et al.
Published: (2019-07-01)

Pseudoxanthoma Elasticum and Cardiorenal Disease: A Case Report
by: Luis D'Marco, et al.
Published: (2019-12-01)

Yinchenhao decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis
by: Fei-Fei Cai, et al.
Published: (2019-06-01)

Heart failure in cardiorenal syndromes
by: E P Kharchenko
Published: (2013-01-01)

Cardiorenal syndrome in thalassemia patients
by: Sorasak Makmettakul, et al.
Published: (2020-08-01)

Causes of development and progression of cardiorenal syndrome in heart failure patients. Prevention methods
by: V. V. Davydov, et al.
Published: (2021-02-01)

Cardiorenal Syndrome Type 1: Definition, Etiopathogenesis, Diagnostics and Treatment
by: Nikolic Tomislav, et al.
Published: (2018-03-01)

Cardiorenal syndromes: pathogenetic, clinicodiagnostic, prognostic and therapeutic aspects
by: Valentin Sergeevich Moiseev, et al.
Published: (2011-12-01)

Exploring the Mechanism of Dangguiliuhuang Decoction Against Hepatic Fibrosis by Network Pharmacology and Experimental Validation
by: Hui Cao, et al.
Published: (2018-03-01)

Si-Miao-Yong-An Decoction attenuates isoprenaline-induced myocardial fibrosis in AMPK-driven Akt/mTOR and TGF-β/SMAD3 pathways
by: Yuqian Zhao, et al.
Published: (2020-10-01)

Rolipram Improves Outcome in a Rat Model of Infant Sepsis-Induced Cardiorenal Syndrome
by: Clark R. Sims, et al.
Published: (2017-05-01)

Cardiorenal syndrome and prerenal azotemia in patients with acute hypertensive encephalopathy
by: V M Baev, et al.
Published: (2013-04-01)

Cardiorenal syndrome in ischemic renal disease (atherosclerotic renovascular hypertension)
by: N A Mukhin, et al.
Published: (2008-08-01)

Qishen decoction suppresses liver fibrosis by downregulating PI3K/Akt/ mTOR signal pathway
by: Shuo-Xi Li, et al.
Published: (2020-06-01)

Insights into the molecular mechanisms of Huangqi decoction on liver fibrosis via computational systems pharmacology approaches
by: Biting Wang, et al.
Published: (2021-07-01)

Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells
by: Dingqi Zhang, et al.
Published: (2020-01-01)

Evaluating the therapeutic efficacy of the Chinese herbal medicine Yishen Tongbi decoction in patients with active rheumatoid arthritis: protocol for a randomized, controlled, noninferiority trial
by: Lianyu Zhao, et al.
Published: (2019-12-01)

Diabetes prevalence and outcomes in hospitalized cardiorenal-syndrome patients with and without hyponatremia
by: Rainer U. Pliquett, et al.
Published: (2020-09-01)

Cardiorenal Syndrome: Emerging Role of Medical Imaging for Clinical Diagnosis and Management
by: Ling Lin, et al.
Published: (2021-07-01)

Cardiorenal syndrome
by: Sabry Omar, et al.
Published: (2013-01-01)

Cardiorenal syndrome in patients with chronic heart failure
by: L. A. Kovalevskaya, et al.
Published: (2015-08-01)

16S rRNA Technology Approach to Explore Mechanism of Qishen Decoction in Improving Nonalcoholic Fatty Liver Fibrosis
by: Bing-Yu Wang, et al.
Published: (2020-01-01)

Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging
by: Emans Mireille E, et al.
Published: (2012-09-01)

Psychosocial stress and quality of life in patients with type 2 cardiorenal syndrome
by: Elena BIVOL, et al.
Published: (2019-03-01)

Diabetes and cardiorenal syndrome: Understanding the “Triple Threat”
by: Srikanta Banerjee, et al.
Published: (2017-09-01)

THE MEASUREMENTS OF BLOOD CLOTTING IN CARDIORENAL SYNDROME IN ELDERLY
by: Ya. A. Naumov, et al.
Published: (2018-06-01)

Cardiorenal links in systemic amyloidosis
by: V V Rameev, et al.
Published: (2013-06-01)

The pathogenetic bases of cardiorenal syndrome
by: I P Beloglazova, et al.
Published: (2012-09-01)

CARDIORENAL SYNDROME IN CHRONIC HEART FAILURE: PATHOGENESIS, DIAGNOSTICS, PROGNOSIS AND OPPORTUNITIES FOR TREATMENT
by: E. A. Medvedeva, et al.
Published: (2017-02-01)

Dissecting the underlying pharmaceutical mechanism of Danggui Buxue decoction acting on idiopathic pulmonary fibrosis with network pharmacology
by: Cai-Ping Zhao, et al.
Published: (2020-06-01)

The Effect of Ethanol Leaf Extract of Cnidosculus Aconitifolius on Cardiorenal Functions in Hypertensive and Normotensive Male Wistar Rats
by: Damilola Alawode, et al.
Published: (2021-09-01)